RxDoctor Payments Data

Mark Miller, DO

Family Medicine · Carrollton, KYNPI 1558474130

Payments from drug & device makers

$488in general payments, 2019–2025

Across 32 payments — averaging $15.26 each. Meals, travel, consulting and speaking fees, gifts and royalties reported by drug and device makers.

  • AbbVie$106
  • GSK$81
  • Novo Nordisk$79
  • Lilly USA, LLC$64
  • Pfizer$39
  • E.r. Squibb & Sons, L.L.C.$32
  • plus $88 from 5 others

What the payments were for

  • Food & beverage$45793%
  • Education$327%

Most of this is food and beverage — typically meals provided during product presentations at a clinic or hospital. Nationally that is the single largest category of reported payments by count.

General payments by program year

19
20
21
22
23
24

Who reported the general payments

Companies are grouped under their corporate parent — a single manufacturer often files under several CMS reporting entities. Research and ownership payments are counted separately and are not in this table.

How this compares

$488 in reported general payments places this provider in the 40th percentile of 1,559 family medicine providers in Kentucky.

See all family medicine providers in Kentucky

Medicare billing

Part B allowed, 2024
$29,713
Medicare patients
83
Services billed
444

What this is not: this is the amount Original Medicare Part B allowed for services this provider billed in 2024. It is not their income. It excludes Medicare Advantage — now more than half of all Medicare enrollment — along with Medicaid and all commercial insurance, and it is gross practice revenue before staff, rent, supplies and malpractice premiums. CMS also suppresses any figure covering ten or fewer patients, so low-volume providers appear smaller than they are.

Most prescribed under Part D

DrugClaimsCost to plans & patients
EliquisApixaban60$62,988
MounjaroTirzepatide14$30,867
JardianceEmpagliflozin17$22,572
OzempicSemaglutide13$22,520
FarxigaDapagliflozin Propanediol12$17,081
SymbicortBudesonide/Formoterol Fumarate12$7,247
Incruse ElliptaUmeclidinium Bromide11$3,420
Albuterol Sulfate HfaAlbuterol Sulfate63$3,172
Lantus SolostarInsulin Glargine,hum.Rec.Anlog17$3,010
SynthroidLevothyroxine Sodium21$1,481
Levothyroxine Sodium126$1,093
Ultra-Fine Mini Pen NeedlePen Needle, Diabetic11$881
Atorvastatin Calcium185$825
Metoprolol Succinate87$742
Fluticasone Propionate47$706

Paid to pharmacies, not to this prescriber.

Companies that both paid and supply prescribed drugs

These companies both reported payments to this provider and make drugs the provider prescribed under Medicare Part D in 2024. For most specialties this overlap is expected — a cardiologist who is paid by a cardiology drugmaker also treats heart disease. It is shown so the reader can see it, not because it implies anything on its own.

CompanyPaid to this providerPart D cost of their drugs
PfizerEliquis$39$62,98860 claims
Lilly USA, LLCMounjaro, Olanzapine$64$31,19327 claims
AstraZenecaFarxiga, Symbicort$22$24,32824 claims
Boehringer IngelheimJardiance$14$22,57217 claims
Novo NordiskOzempic$79$22,52013 claims
GSKIncruse Ellipta$81$3,42011 claims
AbbVieSynthroid$106$1,48121 claims

Reading this fairly. The Part D column is what drug plans and patients paid pharmacies — this provider received none of it, and it reflects how many patients they treat and what those drugs cost. Against peers, this provider's reported payments sit in the 40th percentile of 1,559 family medicine providers in Kentucky.

Other family medicine in Carrollton

See the full list for Kentucky

Where these figures come from

Is this you, or does something look wrong? →